NCT07295236

Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak

Prospective Observational Study on Endo-vac Therapy for Esophago-jejunal Anastomotic Leak

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Ukrainian Society of Clinical Oncology · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following: Primary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.

Detailed description

Patients who are diagnosed with asophago-jejunal anastomotic leakage will undergo endoscopic vacuum therapy. Local source control may be additionally achieved with para-anastomotic drains.

Conditions

• Esophagojejunal Anastomotic Leak

Timeline

• Start date: 2025-12-01
• Primary completion: 2030-12-01
• Completion: 2035-12-01
• First posted: 2025-12-19
• Last updated: 2025-12-29

Locations

1 site across 1 country: Ukraine